Jessica L King1, Beth A Reboussin2, Julie W Merten3, Kimberly D Wiseman4, Kimberly G Wagoner4, Erin L Sutfin4. 1. University of Utah, Department of Health, Kinesiology, & Recreation, 250 S 1820 E, Salt Lake City, UT 84105, USA. Electronic address: jess.king@utah.edu. 2. Wake Forest School of Medicine, Department of Biostatistics and Data Science, Medical Center Boulevard, Winston-Salem, NC 27157, USA. 3. University of North Florida, Brooks College of Health, 1 UNF Drive, Jacksonville, FL 32224, USA. 4. Wake Forest School of Medicine, Department of Social Sciences and Health Policy, Medical Center Boulevard, Winston-Salem, NC 27157, USA.
Abstract
BACKGROUND: E-cigarettes are the most prevalent tobacco product among US youth, but little is known about the health symptoms users experience. METHODS: Between August 2016 and May 2017, we conducted a nationally representative cross-sectional telephone survey of 975 US youth ages 13-17. Respondents who reported ever trying e-cigarettes were asked whether they ever experienced six physical health symptoms they thought were caused by e-cigarette use. We examined whether symptoms varied by demographics and tobacco use. RESULTS: Approximately 12.4% of respondents (n = 141) reported ever trying e-cigarettes. Of lifetime e-cigarette users, 37.0% reported past 30-day e-cigarette use, 17.2% reported past 30-day cigarette use, and 23.7% reported past 30-day use of another tobacco product. Most (63.3%) reported a symptom, most often cough (42.3%), followed by dizziness or lightheadedness (31.5%), headache or migraine (25.4%), dry or irritated mouth or throat (14.9%), shortness of breath (13.7%), change in or loss of taste (3.5%), and other (5.7%; nausea, dry eyes, earache, and tight chest). Headaches were more common among past 30-day e-cigarette users than non-users (43.8% vs. 14.6%). Shortness of breath was more common among past 30-day cigarette (33.8% vs. 9.5%) and other tobacco users (31.6% vs. 8.2%). Past 30-day cigarette users were also more likely to report any symptom (86.0% vs. 58.6%). CONCLUSIONS: Most youth e-cigarette users attribute health symptoms to their e-cigarette use. Past 30-day users were more likely to report certain symptoms than non-users. Findings can educate health practitioners and school nurses about common symptoms youth may experience and inform prevention messages.
BACKGROUND: E-cigarettes are the most prevalent tobacco product among US youth, but little is known about the health symptoms users experience. METHODS: Between August 2016 and May 2017, we conducted a nationally representative cross-sectional telephone survey of 975 US youth ages 13-17. Respondents who reported ever trying e-cigarettes were asked whether they ever experienced six physical health symptoms they thought were caused by e-cigarette use. We examined whether symptoms varied by demographics and tobacco use. RESULTS: Approximately 12.4% of respondents (n = 141) reported ever trying e-cigarettes. Of lifetime e-cigarette users, 37.0% reported past 30-day e-cigarette use, 17.2% reported past 30-day cigarette use, and 23.7% reported past 30-day use of another tobacco product. Most (63.3%) reported a symptom, most often cough (42.3%), followed by dizziness or lightheadedness (31.5%), headache or migraine (25.4%), dry or irritated mouth or throat (14.9%), shortness of breath (13.7%), change in or loss of taste (3.5%), and other (5.7%; nausea, dry eyes, earache, and tight chest). Headaches were more common among past 30-day e-cigarette users than non-users (43.8% vs. 14.6%). Shortness of breath was more common among past 30-day cigarette (33.8% vs. 9.5%) and other tobacco users (31.6% vs. 8.2%). Past 30-day cigarette users were also more likely to report any symptom (86.0% vs. 58.6%). CONCLUSIONS: Most youth e-cigarette users attribute health symptoms to their e-cigarette use. Past 30-day users were more likely to report certain symptoms than non-users. Findings can educate health practitioners and school nurses about common symptoms youth may experience and inform prevention messages.
Authors: Giorgio Romagna; Elena Allifranchini; Elena Bocchietto; Stefano Todeschi; Mara Esposito; Konstantinos E Farsalinos Journal: Inhal Toxicol Date: 2013-05 Impact factor: 2.724
Authors: Jessica L King; David Reboussin; Jennifer Cornacchione Ross; Kimberly D Wiseman; Kimberly G Wagoner; Erin L Sutfin Journal: J Adolesc Health Date: 2018-08-13 Impact factor: 5.012
Authors: Michelle Jeong; Dongyu Zhang; Jennifer C Morgan; Jennifer Cornacchione Ross; Amira Osman; Marcella H Boynton; Jennifer R Mendel; Noel T Brewer Journal: Ann Behav Med Date: 2019-03-28
Authors: Lawrence C An; Carla J Berg; Colleen M Klatt; Cheryl L Perry; Janet L Thomas; Xianghua Luo; Edward Ehlinger; Jasjit S Ahluwalia Journal: Nicotine Tob Res Date: 2009-03-05 Impact factor: 4.244
Authors: Joseph G Allen; Skye S Flanigan; Mallory LeBlanc; Jose Vallarino; Piers MacNaughton; James H Stewart; David C Christiani Journal: Environ Health Perspect Date: 2015-12-08 Impact factor: 9.031
Authors: Marcella H Boynton; Robert P Agans; J Michael Bowling; Noel T Brewer; Erin L Sutfin; Adam O Goldstein; Seth M Noar; Kurt M Ribisl Journal: BMC Public Health Date: 2016-06-23 Impact factor: 3.295
Authors: Kimberly G Wagoner; Jessica L King; Amir Alexander; Hollie L Tripp; Erin L Sutfin Journal: Int J Environ Res Public Health Date: 2021-05-01 Impact factor: 3.390